Skip to content

Tempus AI, Inc. TEM Convertible debentures

Convertible debentures at other companies

Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s convertible debentures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s convertible debentures?
Tempus AI, Inc. (TEM) reported convertible debentures of $199.28M in Q1 2026.
How has Tempus AI, Inc.'s convertible debentures changed year-over-year?
Tempus AI, Inc.'s convertible debentures decreased by 14.7% year-over-year, from $233.62M to $199.28M.
What is the long-term trend for Tempus AI, Inc.'s convertible debentures?
Over 2 years (2023 to 2025), Tempus AI, Inc.'s convertible debentures has grown at a 3.9% compound annual growth rate (CAGR), from $193.12M to $208.67M.